Outset Medical (NASDAQ: OM)
Outset Medical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Outset Medical Company Info
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
News & Analysis
Why Shares of Outset Medical Are Down Monday
The company's issues with the FDA are dragging on.
This Could Be the Best Growth Stock Under $20 on the Market Right Now
Home is where the big money is for this up-and-coming healthcare company.
Why Shares of Outset Medical Are Down Tuesday
The medical technology company, which makes a portable dialysis machine, delivered its fourth-quarter and full-year report on Monday.
These 2 Nasdaq Stocks Got No Valentine's Day Love
Quarterly financial performance left something to be desired from both of these companies.
Why Outset Medical's Shares Rose 22.5% in December
Improved guidance and a big contract attracted investors to the dialysis equipment company.
Supercharged Returns: 2 Growth Stocks That Could Turn $1,000 Into $10,000
Little-known Boston Omaha is a quiet compounder, while Outset Medical's dialysis treatment could change millions of lives.
2 Big Stock Winners From a Horrible Day on Wall Street
If you like gains of 15% to 30%, these stocks are for you.
Outset Medical Stock Is Soaring: Here's Why Even Bigger Gains Could Be Ahead
A major FDA decision clears the way for Outset to again go after a huge opportunity.
Valuation
Podcast Episodes
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.